3

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: September 23, 2022
Period of Report: February 20, 2019
Accession Number: 0001096906-22-002325

View Document ↗ View on SEC.gov ↗